Tumor suppressor PLK2 may serve as a biomarker in triple negative breast cancer for combinational therapy of PLK1 inhibitors with the standard-of-care chemotherapy

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Tumor suppressor PLK2 may serve as a biomarker in triple negative breast cancer for combinational therapy of PLK1 inhibitors with the standard-of-care chemotherapy

【24h】

Tumor suppressor PLK2 may serve as a biomarker in triple negative breast cancer for combinational therapy of PLK1 inhibitors with the standard-of-care chemotherapy

机译：肿瘤抑制器PLK2可以用作三阴性乳腺癌中的生物标志物，用于组合PLK1抑制剂与护理标准化疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Tumor suppressor PLK2 may serve as a biomarker in triple negative breast cancer for combinational therapy of PLK1 inhibitors with the standard-of-care chemotherapy [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：肿瘤抑制器PLK2可以用作三阴性乳腺癌中的生物标志物，用于组合PLK1抑制剂与护理标准化疗
2. Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy [J] . Sohel M. Julovi, Janet L. Martin, Robert C. Baxter Frontiers in Endocrinology . 2018,第2期

机译：核胰岛素样生长因子结合蛋白3作为三阴性乳腺癌异种移植肿瘤中的生物标志物：靶向治疗的效果以及与化学疗法的比较
3. Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer [J] . Chengxiang Zhang, Binbin Deng, David W.McComb, 纳米研究（英文版） . 2019,第004期

机译：化学疗法药物衍生的纳米颗粒包裹了编码肿瘤抑制蛋白的mRNA，可治疗三阴性乳腺癌
4. Optical coherence elastography as a new method for estimation of chemotherapy efficacy on triple-negative breast cancer in the experiment [C] . Anton A. Plekhanov, Marina A. Sirotkina, Alexander A. Sovetsky, International Symposium on Optics and Biophotonics: Saratov Fall Meeting . 2019

机译：光学相干弹性造影作为对实验中三阴性乳腺癌化疗疗效估算的新方法
5. Effects of MicroRNA Modulation of PLK1 in Breast Cancer in Combination with PLK1 Inhibitor NMS-P937 [D] . Zalles, Nicole 2019

机译：联合PLK1抑制剂NMS-P937对乳腺癌中PLK1的微小RNA调节作用。
6. Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy [O] . Sohel M. Julovi, Janet L. Martin, Robert C. Baxter 2018

机译：核胰岛素样生长因子结合蛋白3作为三阴性乳腺癌异种移植肿瘤中的生物标志物：靶向治疗的效果以及与化学疗法的比较
7. Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics [O] . Yang Gao, Elena B. Kabotyanski, Elizabeth Villegas, 2021

机译：肿瘤抑制器PLK2可作为三阴性乳腺癌中的生物标志物，以改善对PLK1治疗的反应

Tumor suppressor PLK2 may serve as a biomarker in triple negative breast cancer for combinational therapy of PLK1 inhibitors with the standard-of-care chemotherapy

著录项

相似文献

相关主题

期刊订阅